Iterative Health, Inc.
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD) and improving the accuracy of colorectal cancer screenings. We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI-related diseases. The company is based in Cambridge, Massachusetts with offices across the United States.
Company details
Find locations served, office locations
- Business Type:
- Technology
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Nationally (across the country)
- Year Founded:
- 2017
- Employees:
- 101-1000
Our Mission
Our team is on a mission to develop technology that can benefit patients anywhere, regardless of socioeconomic or geographic barriers.
By using machine learning and artificial intelligence to augment human perception, we’re creating a higher worldwide standard for gastrointestinal care. Our strategy is scalable. It’s sustainable. Most importantly, it’s attainable.
We believe that timely access to quality healthcare should be embraced as nothing less than a basic human right. We believe our progress as a company will play an important role in making this vision a reality.